Iryna
Iryna Andriyanova, Rennes FR
Patent application number | Description | Published |
---|---|---|
20080201631 | Method for Error Correction Coding Comprising Local Error Detection Codes, Corresponding Decoding Method, Transmitting, Receiving and Storage Device and Program - The disclosure relates to a coding method for associating redundant and source data and for carrying out a plurality of local codes associating at least one input status word and at least one output status word according to at least one label word and permutations applicable on at least certain of said words. The local codes are embodied in the form of detection codes and not error correction codes on a predetermined coding alphabet. The local codes are interconnected by the status words in such a way that at least one coding matrix is formed, each of which defining a base code. | 08-21-2008 |
Iryna Grafova, Vantaa FI
Patent application number | Description | Published |
---|---|---|
20130095323 | Method of producing inorganic layered double hydroxides, novel inorganic layered double hydroxides and uses of the same - Novel nanosized layered double hydroxide materials and a method of producing the same as well as uses of said material. The novel materials are uniform and have the general formula I | 04-18-2013 |
Iryna Ilyk, Houston, TX US
Patent application number | Description | Published |
---|---|---|
20150096952 | CABLE MANAGEMENT SYSTEM - Embodiments of the disclosure generally relate to a cable management system for use in the petrochemical industry. In one embodiment, a cable management system is provided. The cable management system includes an arm assembly coupled to a base that is movable relative to a track structure, wherein the arm assembly includes a first end to couple to a movable platform that moves the arm assembly during movement of the movable platform, and a second end of the arm assembly is coupled to the base and is movable relative to the base during movement of the movable platform. | 04-09-2015 |
Iryna Issayeva, Foster City, CA US
Patent application number | Description | Published |
---|---|---|
20140125557 | METHOD AND APPARATUS FOR A THREE DIMENSIONAL INTERFACE - Method and apparatus for interacting with a three dimensional interface. In the method, a three dimensional interface with at least one virtual object is generated. An interaction zone is defined and generated, enclosing some or all of the object. A stimulus of the interaction zone, e.g. approach/contact with a finger/stylus is defined, and a response to the stimulus is defined, e.g. changes to the object, system actions, feedback, etc. When the stimulus is sensed the response is executed. The apparatus includes a processor that generates a three dimensional interface with at least one virtual object, defines an interaction zone for the object, and defines a stimulus and a response. A display outputs the interface and object. A camera or other sensor detects stimulus of the interaction zone, whereupon the processor generates a response signal. The apparatus may be part of a head mounted display. | 05-08-2014 |
Iryna Makovey, Cleveland Heights, OH US
Patent application number | Description | Published |
---|---|---|
20120220518 | THERAPEUTIC AGENT DELIVERY SYSTEM AND METHOD - A therapeutic agent delivery system includes a therapeutic agent delivery platform and a therapeutic guest agent. The therapeutic agent delivery platform is capable of being implanted in a tissue being treated. The platform includes a substrate and at least one host molecule coupled to the substrate. The therapeutic guest agent is capable of reversibly coupling with the host molecule when administered to the tissue being treated. The reversible coupling is defined by the binding affinity between the host molecule and the therapeutic guest agent. The therapeutic guest agent is delivered at a rate determined by the affinity release rate between the host molecule and the therapeutic guest agent. The degradation rate of the therapeutic guest agent may be slower than the affinity release rate between the host molecule and the therapeutic guest agent. | 08-30-2012 |
Iryna Schlackow, Oxford GB
Patent application number | Description | Published |
---|---|---|
20140136556 | METHODS AND SYSTEMS FOR MONITORING THE SEVERITY OF INFECTION IN A GROUP OF INDIVIDUALS - A computer-implemented method of monitoring the severity of infection in a group of individuals. A set of data for each individual is obtained, the data comprising at least one piece of diagnostic test data indicating the level of a biomarker associated with the individual's response to infection. The data is then split into a plurality of segments, each segment comprising all data for each individual within a corresponding one of a plurality of time periods. For each segment, a level of the biomarker across the group of individuals during the time period is estimated. The level of the biomarker for each segment to is then determined provide an indication of the change in severity of infection in the group of individuals over time. | 05-15-2014 |
Iryna Ursic, Sempeter Pri Gorici SI
Patent application number | Description | Published |
---|---|---|
20100125045 | COSMETIC OR TOILET PREPARATION - The present invention relates to cosmetic or similar toilet preparations in particular to a container for storing and/or use of a cosmetic or similar toilet preparation in solid form, and preferably to a container for storing and/or use of a soap for personal use. It is provided for, according to the invention, that a container ( | 05-20-2010 |
Iryna Valyukh, Mantorp SE
Patent application number | Description | Published |
---|---|---|
20120242918 | Cholesteric liquid crystal structure - A liquid crystal optical device that includes a first substrate layer that is substantially flat and a second substrate layer that is substantially flat and parallel to the first substrate layer. The liquid crystal optical device further includes a layer of cholesteric liquid crystal disposed between the first substrate layer and the second substrate layer, where the layer of cholesteric liquid crystal is arranged in domains, each domain having a helical axis, wherein the helical axes of the domains have a plurality of orientations relative to an orientation of the first and second substrate layers, and where a wavefront of a light wave having a wavelength within a range of wavelengths changes after reflecting from the layer of cholesteric liquid crystal. | 09-27-2012 |
Iryna Vogler-Ivashchanka, Los Altos, CA US
Patent application number | Description | Published |
---|---|---|
20080228670 | Interacting with a user via a personal information manager user interface - Systems and techniques for interacting with a user via a personal information manager user interface. In another aspect, a system can include a recruiting server that provides services related to a recruiting process and manages data associated with the recruiting process, a personal information manager server that provides services related to management of a user's personal information, and a personal information manager user interface on one or more I/O devices. The personal information manager user interface can integrates, into a single display screen, personal information from the personal information manager server and the data associated with the recruiting process. | 09-18-2008 |
Iryna Ziabreva, Wardley Gateshead GB
Patent application number | Description | Published |
---|---|---|
20090317325 | Diagnostic Substance and Method for the Analysis of Metabolism Processes in the Brain - The present invention relates to a diagnostic substance, containing at least one complex of lipophilic anions and metal ions, wherein the lipophilic anions are selected from the group comprising: triethylene tetramine dihydrochloride (TETA), ethyl cysteinate dimer (ECD), methoxyisobutylisonitrile (MIBI), HMPAO (d,l-hexamethylpropylene aminoxime), ethylenediamine N,N,N′,N′-tetraacetanilide (EDTAN), dimethyldithiocarbamate (DMC) and diethyldithiocarbamate (DDC) and glycine N,N′-[1,2-ethanediylbis(oxy-2,1-phenylene)]bis [N-(carboxymethyl)-1,1′-bis[2-(octadecyloxy)ethyl]ester (DP-109), and wherein the metal ions are selected from the group comprising thallium isotopes, lead isotopes, cobalt isotopes and manganese isotopes, together with solvents, adjuvants and/or vehicles. The diagnostic substance is used for investigating metabolic processes in the brain and/or central nervous system (CNS). | 12-24-2009 |